{"id":"https://openalex.org/W2017433329","doi":"https://doi.org/10.1097/yic.0b013e3282f41d7e","title":"Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine","display_name":"Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine","publication_year":2008,"publication_date":"2008-05-01","ids":{"openalex":"https://openalex.org/W2017433329","doi":"https://doi.org/10.1097/yic.0b013e3282f41d7e","mag":"2017433329","pmid":"https://pubmed.ncbi.nlm.nih.gov/18408530"},"language":"en","primary_location":{"id":"doi:10.1097/yic.0b013e3282f41d7e","doi":"https://doi.org/10.1097/yic.0b013e3282f41d7e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yic.0b013e3282f41d7e","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081426855","display_name":"Madhukar H. Trivedi","orcid":"https://orcid.org/0000-0002-2983-1110","observed_orcids":["https://orcid.org/0000-0002-2983-1110"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Madhukar H. Trivedi","raw_affiliation_strings":["Mood Disorders Program and Clinic, University of Texas Southwestern Medical School, Dallas, TX 75235-9119, USA. Madhukar.Trivedi@UTSouthwestern.edu","Mood Disorders Program and Clinic, University of Texas Southwestern Medical School, Dallas, Texas","to Madhukar H. Trivedi, MD, Mood Disorders Program and Clinic, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, Texas 75235-9119, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mood Disorders Program and Clinic, University of Texas Southwestern Medical School, Dallas, TX 75235-9119, USA. Madhukar.Trivedi@UTSouthwestern.edu","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"Mood Disorders Program and Clinic, University of Texas Southwestern Medical School, Dallas, Texas","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"to Madhukar H. Trivedi, MD, Mood Disorders Program and Clinic, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, Texas 75235-9119, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007350826","display_name":"Durisala Desaiah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Durisala Desaiah","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041088940","display_name":"Melissa J. Ossanna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa J. Ossanna","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034584090","display_name":"Yili Pritchett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yili L. Pritchett","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019090648","display_name":"Stephen K. Brannan","orcid":"https://orcid.org/0000-0003-0922-5970","observed_orcids":["https://orcid.org/0000-0003-0922-5970"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen K. Brannan","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113644572","display_name":"Michael J. Detke","orcid":"https://orcid.org/0000-0002-2195-8651","observed_orcids":["https://orcid.org/0000-0002-2195-8651"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Detke","raw_affiliation_strings":["Harvard Medical School, Boston, Massachusetts, USA","Indiana University School of Medicine, Indianapolis, Indiana","Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Indiana University School of Medicine, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5081426855"],"corresponding_institution_ids":["https://openalex.org/I867280407"],"apc_list":null,"apc_paid":null,"fwci":0.7183,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.56584362,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"23","issue":"3","first_page":"161","last_page":"169"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":1.0},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibition","display_name":"serotonin reuptake inhibition","score":0.9660000205039978},{"id":"https://openalex.org/keywords/noradrenaline-reuptake-inhibition","display_name":"norepinephrine reuptake inhibition","score":0.9990000128746033},{"id":"https://openalex.org/keywords/serotonin-norepinephrine-reuptake-inhibitors","display_name":"serotonin-norepinephrine reuptake inhibitors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9359999895095825},{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.890999972820282},{"id":"https://openalex.org/keywords/diabetic-peripheral-neuropathic-pain","display_name":"diabetic peripheral neuropathic pain","score":0.9929999709129333},{"id":"https://openalex.org/keywords/fibromyalgia","display_name":"fibromyalgia","score":0.9300000071525574},{"id":"https://openalex.org/keywords/cardiovascular-effects","display_name":"cardiovascular effects","score":0.9160000085830688},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8700000047683716},{"id":"https://openalex.org/keywords/antidepressant-mechanism-of-action","display_name":"antidepressant mechanism","score":0.8539999723434448}],"concepts":[{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.8989123702049255},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.7612917423248291},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.6605321168899536},{"id":"https://openalex.org/C2910564767","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine Hydrochloride","level":4,"score":0.5824207663536072},{"id":"https://openalex.org/C176233148","wikidata":"https://www.wikidata.org/wiki/Q14874257","display_name":"Norepinephrine transporter","level":4,"score":0.4759257137775421},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.4675527811050415},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.4633875787258148},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45492568612098694},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.4509418308734894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4380481541156769},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.4356911778450012},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.42145836353302},{"id":"https://openalex.org/C2993285035","wikidata":"https://www.wikidata.org/wiki/Q2643251","display_name":"Synaptic cleft","level":4,"score":0.42022523283958435},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.38042622804641724},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3725743293762207},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.36457496881484985},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3605549931526184},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.2508414387702942},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.22598764300346375},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.13137760758399963},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0878499448299408},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.06247994303703308},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068736","descriptor_name":"Duloxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050484","descriptor_name":"Norepinephrine Plasma Membrane Transport Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D050484","descriptor_name":"Norepinephrine Plasma Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/yic.0b013e3282f41d7e","doi":"https://doi.org/10.1097/yic.0b013e3282f41d7e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yic.0b013e3282f41d7e","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:18408530","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18408530","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":113,"referenced_works":["https://openalex.org/W50948397","https://openalex.org/W51209413","https://openalex.org/W51362970","https://openalex.org/W60025275","https://openalex.org/W105240579","https://openalex.org/W131184388","https://openalex.org/W180447486","https://openalex.org/W1492022547","https://openalex.org/W1498726486","https://openalex.org/W1733210104","https://openalex.org/W1809195245","https://openalex.org/W1846318813","https://openalex.org/W1850232980","https://openalex.org/W1858338717","https://openalex.org/W1867335213","https://openalex.org/W1922363637","https://openalex.org/W1930454256","https://openalex.org/W1963482722","https://openalex.org/W1971393265","https://openalex.org/W1971681841","https://openalex.org/W1973824257","https://openalex.org/W1974622200","https://openalex.org/W1982112913","https://openalex.org/W1982721912","https://openalex.org/W1984259090","https://openalex.org/W1985193354","https://openalex.org/W1985244478","https://openalex.org/W1988861786","https://openalex.org/W1989915234","https://openalex.org/W1990079987","https://openalex.org/W1990917297","https://openalex.org/W1994256806","https://openalex.org/W1994639499","https://openalex.org/W1996298226","https://openalex.org/W1997499592","https://openalex.org/W1997685981","https://openalex.org/W2000169475","https://openalex.org/W2001535321","https://openalex.org/W2002146908","https://openalex.org/W2002519594","https://openalex.org/W2003363634","https://openalex.org/W2008347627","https://openalex.org/W2008571936","https://openalex.org/W2009549897","https://openalex.org/W2011003051","https://openalex.org/W2014511346","https://openalex.org/W2018425549","https://openalex.org/W2021189780","https://openalex.org/W2021817727","https://openalex.org/W2029503234","https://openalex.org/W2031937662","https://openalex.org/W2035817582","https://openalex.org/W2037633842","https://openalex.org/W2041481324","https://openalex.org/W2041814518","https://openalex.org/W2043595892","https://openalex.org/W2045126499","https://openalex.org/W2047902057","https://openalex.org/W2048519309","https://openalex.org/W2048854747","https://openalex.org/W2061271938","https://openalex.org/W2069090735","https://openalex.org/W2069970023","https://openalex.org/W2071535163","https://openalex.org/W2071709883","https://openalex.org/W2075514284","https://openalex.org/W2076065290","https://openalex.org/W2076728061","https://openalex.org/W2082857343","https://openalex.org/W2084168719","https://openalex.org/W2087237399","https://openalex.org/W2089659183","https://openalex.org/W2091061257","https://openalex.org/W2092191605","https://openalex.org/W2093196756","https://openalex.org/W2099564543","https://openalex.org/W2104568028","https://openalex.org/W2106059433","https://openalex.org/W2106574039","https://openalex.org/W2109163290","https://openalex.org/W2111435625","https://openalex.org/W2122136364","https://openalex.org/W2126095527","https://openalex.org/W2127907569","https://openalex.org/W2130825385","https://openalex.org/W2137296158","https://openalex.org/W2141371342","https://openalex.org/W2141398558","https://openalex.org/W2147289447","https://openalex.org/W2148694444","https://openalex.org/W2157229623","https://openalex.org/W2163446367","https://openalex.org/W2168305909","https://openalex.org/W2169741270","https://openalex.org/W2170273380","https://openalex.org/W2210637379","https://openalex.org/W2314756433","https://openalex.org/W2323218599","https://openalex.org/W2326556388","https://openalex.org/W2328445755","https://openalex.org/W2341970774","https://openalex.org/W2404950077","https://openalex.org/W2407115578","https://openalex.org/W2410702893","https://openalex.org/W2468424440","https://openalex.org/W2885942243","https://openalex.org/W2994532047","https://openalex.org/W4239770802","https://openalex.org/W4242017832","https://openalex.org/W4244704374","https://openalex.org/W4293772167","https://openalex.org/W4299844232","https://openalex.org/W4321428484"],"related_works":["https://openalex.org/W2390985240","https://openalex.org/W2141371342","https://openalex.org/W2061271938","https://openalex.org/W2103670903","https://openalex.org/W2136193465","https://openalex.org/W2339020899","https://openalex.org/W3198402554","https://openalex.org/W2018664808","https://openalex.org/W2021817727","https://openalex.org/W2008136659"],"abstract_inverted_index":{"Most":[0],"antidepressants":[1],"in":[2,175,193],"clinical":[3,115,129,179],"use":[4],"are":[5,196],"believed":[6,161],"to":[7,39,156,162],"function":[8],"by":[9],"enhancing":[10],"neurotransmission":[11],"of":[12,21,28,46,59,92,100,107,119,145,167,181],"serotonin":[13],"[5-hydroxytryptamine":[14],"(5-HT)]":[15],"and/or":[16],"norepinephrine":[17],"(NE)":[18],"via":[19],"inhibition":[20,137,166,192],"neurotransmitter":[22],"reuptake.":[23,169],"Agents":[24],"that":[25,84],"affect":[26],"reuptake":[27,34,106,126,136,191,203],"both":[29,108,187],"5-HT":[30,109,123,188],"and":[31,65,77,97,110,116,124,150,189,195],"NE":[32,125,135,146,168,190],"(serotonin-norepinephrine":[33],"inhibitors)":[35],"have":[36],"been":[37],"postulated":[38],"offer":[40],"greater":[41],"efficacy":[42,62],"for":[43,63,89,158,184,201],"the":[44,90,98,165,172],"treatment":[45,91],"major":[47],"depressive":[48],"disorder":[49],"(MDD).":[50],"These":[51],"dual-acting":[52],"agents":[53],"also":[54],"display":[55],"a":[56,182],"broader":[57],"spectrum":[58],"action,":[60],"including":[61],"MDD":[64],"associated":[66],"painful":[67],"physical":[68],"symptoms,":[69],"diabetic":[70,101],"peripheral":[71,102],"neuropathic":[72,103],"pain,":[73,104],"generalized":[74,94],"anxiety":[75,95],"disorder,":[76,96],"fibromyalgia":[78],"syndrome.":[79],"Substantial":[80],"preclinical":[81,199],"evidence":[82,118,130,180,200],"shows":[83],"duloxetine,":[85],"an":[86],"approved":[87],"drug":[88],"MDD,":[93],"management":[99],"inhibits":[105],"NE.":[111],"This":[112],"paper":[113],"reviews":[114],"neurochemical":[117],"duloxetine's":[120,132],"effects":[121,133],"on":[122,134],"inhibition.":[127,204],"The":[128],"supporting":[131],"includes":[138],"indirect":[139],"measures":[140],"such":[141],"as":[142],"altered":[143],"excretion":[144],"metabolites,":[147],"cardiovascular":[148],"effects,":[149],"treatment-emergent":[151],"adverse":[152],"event":[153],"profiles":[154],"similar":[155],"those":[157],"other":[159],"drugs":[160],"act":[163],"through":[164],"In":[170],"summary,":[171],"data":[173],"presented":[174],"this":[176],"report":[177],"provide":[178],"mechanism":[183],"duloxetine":[185],"involving":[186],"humans":[194],"consistent":[197],"with":[198],"5-HT/NE":[202]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}